Description
THEÂ FINANCIAL TIMESÂ & MCKINSEY BUSINESS BOOK OF THE YEAR NEW YORK TIMESÂ NOTABLE BOOK AÂ WASHINGTON POSTÂ NOTABLE BOOKIn 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the next Steve Jobs: a brilliant Stanford dropout whose startup “unicorn” promised to revolutionize the medical industry with its breakthrough device, which performed the whole range of laboratory tests from a single drop of blood. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.5 billion.